Shanghai Shen Lian Biomedical Corp Class A 688098
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 5.12
- Day Range
- CNY 4.84–5.12
- 52-Week Range
- CNY 4.18–8.13
- Bid/Ask
- CNY 4.87 / CNY 4.88
- Market Cap
- CNY 2.00 Bil
- Volume/Avg
- 2.3 Mil / 2.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- 233.46
- Price/Sales
- 6.59
- Dividend Yield (Trailing)
- 1.57%
- Dividend Yield (Forward)
- 1.57%
- Total Yield
- 1.57%
Company Profile
Shanghai Shen Lian Biomedical Corp is engaged in the development, production and sales of veterinary biological products.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 380
- Website
- http://www.slbio.com.cn
Comparables
Valuation
|
Metric
|
688098
|
688197
|
688639
|
|---|---|---|---|
Price/Earnings (Normalized) | 233.46 | — | 32.48 |
Price/Book Value | 1.41 | 6.66 | 7.84 |
Price/Sales | 6.59 | 1,232.65 | 7.37 |
Price/Cash Flow | 167.43 | — | 141.39 |
Price/Earnings
688098
688197
688639
Financial Strength
|
Metric
|
688098
|
688197
|
688639
|
|---|---|---|---|
Quick Ratio | 7.49 | 5.50 | 0.36 |
Current Ratio | 9.41 | 8.50 | 0.62 |
Interest Coverage | — | −2,090.39 | 30.56 |
Quick Ratio
688098
688197
688639
Profitability
|
Metric
|
688098
|
688197
|
688639
|
|---|---|---|---|
Return on Assets (Normalized) | 1.01% | −18.00% | 14.17% |
Return on Equity (Normalized) | 1.08% | −19.55% | 25.94% |
Return on Invested Capital (Normalized) | 1.02% | −21.58% | 18.25% |
Return on Assets
688098
688197
688639
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Ktxzlndwkh | Klkt | $590.5 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Rljpdpfx | Rcszft | $113.8 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Jkbkncnbk | Ktbdjq | $108.0 Bil | |
MRNA
| Moderna Inc | Gczptyxp | Stn | $54.6 Bil | |
BNTX
| BioNTech SE ADR | Prvvxjdf | Bjmrl | $24.2 Bil | |
ARGX
| argenx SE ADR | Ngtcblvj | Lbygw | $21.9 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Kvvnqkk | Gkywh | $18.8 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Xyjhyqcn | Sfcjf | $14.3 Bil | |
INCY
| Incyte Corp | Shxfymyr | Bvxhwm | $13.0 Bil | |
RPRX
| Royalty Pharma PLC Class A | Fpplkrrlz | Rfzbdv | $12.4 Bil |